---
schema_version: "secwatch.filing_event.v1"
accession: "0002031090-25-000015"
form_type: "8-K"
ticker: "PRA"
cik: "0001127703"
company_name: "PROASSURANCE CORP"
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:27:01.735682+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ProAssurance reports Q2 net income $21.9M ($0.42 EPS); merger with Doctors Co. on track

## Summary
- Net income $21.9M ($0.42 diluted EPS); operating income $26.8M ($0.52 diluted EPS) for Q2 2025.
- Specialty P&C net premiums written stable at $135.9M; renewal premium increases of 10% (cumulative >70% since 2018).
- Non-GAAP combined ratio improved 9.5 ppts YoY; net investment income up 6%.
- Book value per share $24.80, up $1.31 from year-end; adjusted book value $27.07.
- Stockholders approved merger with The Doctors Company; FTC granted early termination; expected close H1 2026.

## SEC filing metadata
- accession: 0002031090-25-000015
- form_type: 8-K
- ticker: PRA
- cik: 0001127703
- company_name: PROASSURANCE CORP
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1127703/000203109025000015/0002031090-25-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1127703/000203109025000015/pra-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002031090-25-000015
- JSON: https://secwatch.observer/filing/0002031090-25-000015.json
- Plain text: https://secwatch.observer/filing/0002031090-25-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.